Home > Share Market > Stocks > Bafna pharmaceuticals > Financial Statements> BAFNAPH Profit & Loss

Bafna Pharmaceuticals Ltd Financial Statements

Profit & Loss Statement of Bafna Pharmaceuticals Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Revenue 42.50 43.40 47.20 65
yoy growth (%) (2) (8.10) (27) (24)
Raw materials (20) (28) (38) (52)
As % of sales 47.10 64.10 81.20 79.90
Employee costs (10) (9) (7.50) (6.80)
As % of sales 24.10 20.80 15.80 10.50
Other costs (11) (20) (37) (12)
As % of sales 25.90 45.90 77.50 18.50
Operating profit 1.22 (13) (35) (5.80)
OPM 2.88 (31) (74) (8.90)
Depreciation (3.30) (3.50) (4) (4.20)
Interest expense (0.10) (2.10) (6.90) (11)
Other income 0.26 0.65 31.30 1.14
Profit before tax (1.90) (18) (15) (20)
Taxes -- (1.10) (2.20) 0.90
Tax rate -- 5.84 14.90 (4.40)
Minorities and other (0.30) (0.50) 0.17 --
Adj. profit (2.20) (20) (17) (19)
Exceptional items (23) 1.01 -- --
Net profit (25) (19) (17) (19)
yoy growth (%) 31 12.80 (14) 38.70
NPM (58) (44) (35) (30)

Invest in at ZERO Delivery Brokerage. Join 22 Lac+ Happy Clients